Literature DB >> 19139290

Voriconazole use for endemic fungal infections.

Alison Freifeld1, Laurie Proia, David Andes, Larry M Baddour, Janis Blair, Brad Spellberg, Sandra Arnold, Arnold Lentnek, L Joseph Wheat.   

Abstract

In a retrospective review of 24 patients with histoplasmosis, blastomycosis, or coccidioidomycosis treated with voriconazole (most for salvage therapy), the outcome was favorable (improved or stable) for 22 (95.8%) within 2 months of starting voriconazole and for 20 (83.3%) at the last follow-up. Prospective studies are required to determine its role in the treatment of endemic mycoses.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19139290      PMCID： PMC2663067          DOI： 10.1128/AAC.01148-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  26 in total

1.  Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center.

Authors:  A G Freifeld; P C Iwen; B L Lesiak; R K Gilroy; R B Stevens; A C Kalil
Journal:  Transpl Infect Dis       Date:  2005 Sep-Dec       Impact factor: 2.228

Review 2.  Coccidioidomycosis.

Authors:  John N Galgiani; Neil M Ampel; Janis E Blair; Antonino Catanzaro; Royce H Johnson; David A Stevens; Paul L Williams
Journal:  Clin Infect Dis       Date:  2005-09-20       Impact factor: 9.079

3.  A 43-year-old woman with acquired immunodeficiency syndrome and fever of undetermined origin. Disseminated histoplasmosis.

Authors:  Osama M Al-Agha; Mohamad Mooty; Afshin Salarieh
Journal:  Arch Pathol Lab Med       Date:  2006-01       Impact factor: 5.534

Review 4.  Intramedullary histoplasmosis spinal cord abscess in a nonendemic region: case report and review of the literature.

Authors:  Jonathan S Hott; Eric Horn; Volker K H Sonntag; Stephen W Coons; Andrew Shetter
Journal:  J Spinal Disord Tech       Date:  2003-04

5.  In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi.

Authors:  Gloria M González; Annette W Fothergill; Deanna A Sutton; Michael G Rinaldi; David Loebenberg
Journal:  Med Mycol       Date:  2005-05       Impact factor: 4.076

6.  Fungal infections in transplant recipients receiving alemtuzumab.

Authors:  D S Nath; R Kandaswamy; R Gruessner; D E R Sutherland; D L Dunn; A Humar
Journal:  Transplant Proc       Date:  2005-03       Impact factor: 1.066

Review 7.  Serology of coccidioidomycosis.

Authors:  D Pappagianis; B L Zimmer
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

8.  Successful treatment of cerebral blastomycosis with voriconazole.

Authors:  Mohanad Bakleh; Allen J Aksamit; Imad M Tleyjeh; William F Marshall
Journal:  Clin Infect Dis       Date:  2005-03-22       Impact factor: 9.079

9.  In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.

Authors:  R K Li; M A Ciblak; N Nordoff; L Pasarell; D W Warnock; M R McGinnis
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

10.  Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole.

Authors:  Rajesh M Prabhu; Mark Bonnell; Bradford L Currier; Robert Orenstein
Journal:  Clin Infect Dis       Date:  2004-09-10       Impact factor: 9.079
View more
  32 in total

Review 1.  Antifungal clinical trials and guidelines: what we know and do not know.

Authors:  Peter G Pappas
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

2.  Fusarium peritonitis successfully managed with posaconazole and catheter removal.

Authors:  Punit J Shah; Scott Bergman; Srivalli Vegi; Vidya Sundareshan
Journal:  Perit Dial Int       Date:  2014 Jul-Aug       Impact factor: 1.756

3.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

4.  Disseminated histoplasmosis in a patient with aplastic anemia.

Authors:  Sanjeev Kumar Sharma; Sunil Gupta; Prashant Durgapal; Anjan Mukherjee; Tulika Seth; Pravas Mishra; Manoranjan Mahapatra; Immaculata Xess; Ruma Ray; Sanjay Sharma
Journal:  Indian J Hematol Blood Transfus       Date:  2012-10-09       Impact factor: 0.900

5.  Use of Antifungal Combination Therapy: Agents, Order, and Timing.

Authors:  Melissa D Johnson; John R Perfect
Journal:  Curr Fungal Infect Rep       Date:  2010-05-01

Review 6.  Clinical and laboratory update on blastomycosis.

Authors:  Michael Saccente; Gail L Woods
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 7.  Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis.

Authors:  Chinh Nguyen; Bridget Marie Barker; Susan Hoover; David E Nix; Neil M Ampel; Jeffrey A Frelinger; Marc J Orbach; John N Galgiani
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

8.  Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).

Authors:  C A Kauffman; A G Freifeld; D R Andes; J W Baddley; L Herwaldt; R C Walker; B D Alexander; E J Anaissie; K Benedict; J I Ito; K M Knapp; G M Lyon; K A Marr; V A Morrison; B J Park; T F Patterson; M G Schuster; T M Chiller; P G Pappas
Journal:  Transpl Infect Dis       Date:  2014-03-04       Impact factor: 2.228

Review 9.  Dimorphic fungal osteoarticular infections.

Authors:  B Rammaert; M N Gamaletsou; V Zeller; C Elie; R Prinapori; S J Taj-Aldeen; E Roilides; D P Kontoyiannis; B Brause; N V Sipsas; T J Walsh; O Lortholary
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-18       Impact factor: 3.267

Review 10.  Progressive disseminated histoplasmosis in the HIV population in Europe in the HAART era. Case report and literature review.

Authors:  R Martin-Iguacel; J Kurtzhals; G Jouvion; S D Nielsen; J M Llibre
Journal:  Infection       Date:  2014-03-14       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.